Shalby Ltd. Partners with BSDU to Launch Healthcare Education Programs

1 min read     Updated on 25 Aug 2025, 03:22 PM
scanx
Reviewed by
Suketu GalaBy ScanX News Team
whatsapptwittershare
Overview

Shalby Ltd. has signed an MoU with Bhartiya Skill Development University in Jaipur to offer B.Voc. programs in Allied Health and Paramedic Skills. The partnership will introduce three programs: Medical Laboratory Technology, Operation Theatre & Anesthesia Technology, and Medical Radiology Imaging Technology. The programs will follow a Swiss Dual Learning Model, combining clinical training at Shalby Hospitals with academic learning at BSDU. Top-performing students will receive preferential placement opportunities within the Shalby Hospital network. This collaboration aims to address the increasing demand for qualified healthcare professionals.

17661183

*this image is generated using AI for illustrative purposes only.

Shalby Ltd. has announced a significant partnership in the field of healthcare education, signing a Memorandum of Understanding (MoU) with Bhartiya Skill Development University (BSDU) in Jaipur. This collaboration aims to jointly offer Bachelor of Vocation (B.Voc.) programs in Allied Health and Paramedic Skills, marking Shalby Academy's 11th academic partnership across India and its second in Rajasthan.

Program Details

The partnership will introduce three B.Voc. programs:

  1. Medical Laboratory Technology (MLT)
  2. Operation Theatre & Anesthesia Technology (OT&AT)
  3. Medical Radiology Imaging Technology (MRIT)

These programs will follow a Swiss Dual Learning Model, combining practical experience with academic learning:

  • Four days of clinical training at Shalby Hospitals
  • Two days of academic learning at BSDU

Industry-Aligned Curriculum

Shalby Ltd., as the industry partner, will provide hands-on training opportunities at its state-of-the-art facilities in Jaipur. This real-world exposure will be integrated into the academic curriculum, ensuring students gain valuable practical experience alongside their theoretical studies.

Career Opportunities

Top-performing students in these programs will receive preferential placement opportunities within the Shalby Hospital network, providing a clear path to employment in the healthcare sector.

Key Figures Present at MoU Signing

The MoU signing ceremony was attended by several notable figures:

  • Dr. Shaikh Juned Saoud, Registrar, BSDU
  • Mr. Babu Thomas, Group CHRO of Shalby Ltd.
  • Mr. Rolf P. Siebold, CEO, Rajendra Urshula Joshi Trust
  • Ms. Silvia Rosery, Project Manager, Rajendra Urshula Joshi Trust
  • Mr. Sudeep Khanna, Provost, BSDU

Addressing Healthcare Sector Demands

This collaboration is positioned to play a crucial role in addressing the increasing demand for qualified professionals in the healthcare sector. By combining academic rigor with real-world expertise, Shalby Ltd. and BSDU aim to produce industry-ready healthcare professionals.

The partnership underscores Shalby's commitment to developing skilled healthcare professionals through academic synergy, further solidifying its position in the healthcare education landscape.

Historical Stock Returns for Shalby

1 Day5 Days1 Month6 Months1 Year5 Years
-1.70%-4.63%-8.50%-3.27%-30.06%+116.75%

Shalby Limited Reports Mixed Q1 Results with Revenue Crossing INR 300 Crores

1 min read     Updated on 19 Aug 2025, 03:25 PM
scanx
Reviewed by
Naman SharmaBy ScanX News Team
whatsapptwittershare
Overview

Shalby Limited achieved record consolidated revenue of INR 303 crores in Q1, up 12.30% QoQ and 5.10% YoY. EBITDA rose 85.60% QoQ to INR 48.50 crores but declined 11.60% YoY. PAT increased 163% QoQ to INR 7.70 crores, down 47% YoY. Hospital occupancy dropped to 45%, while ARPOB increased 5.3%. The implant business saw 74.2% revenue growth. Management targets 12-15% consolidated revenue growth for FY2026 and aims to improve occupancy to over 50%.

17142961

*this image is generated using AI for illustrative purposes only.

Shalby Limited , a leading multi-specialty hospital chain, has reported mixed results for the first quarter, with consolidated revenue crossing the INR 300 crore mark for the first time in the company's history.

Financial Highlights

Metric Value QoQ Change YoY Change
Consolidated Revenue INR 303.00 crores 12.30% 5.10%
Consolidated EBITDA INR 48.50 crores 85.60% -11.60%
EBITDA Margin 16.00% - -
Consolidated PAT INR 7.70 crores 163.00% -47.00%

Operational Performance

  • Hospital business faced challenges with occupancy dropping to 45% from 49.5% in the previous quarter.
  • Average Revenue Per Occupied Bed (ARPOB) rose 5.3% to INR 45,673.
  • Shalby Sanar's revenue fell 2.2% to INR 23.25 crores due to geopolitical issues affecting international patients.

Implant Business Growth

The implant business, operated under Shalby MedTech, showed strong growth:

  • Revenue up 74.2% to INR 30.80 crores
  • Reduced EBITDA losses
  • Total 14,076 implant components sold, a 65.4% year-on-year increase

Management Outlook

  • Management expects 12-15% consolidated revenue growth for FY2026.
  • Targeting occupancy improvement to 50%+ levels.
  • Aiming for $100 million implant revenue in 4-5 years.

Segment-wise Performance

The company provided a breakdown of hospital performance based on maturity:

Hospital Age Performance
Over 10 years EBITDA of INR 32.00 crores with a 36% margin
5-10 years 17% EBITDA margin with potential for growth
0-5 years Includes franchisee operations and Sanar International Hospital

International Business

  • Shalby Sanar in Delhi saw a dip in international patient flow due to geopolitical issues in the Middle East.
  • The company is focusing on increasing domestic patient inflow to balance the mix.

Future Plans

  • Mumbai hospital project expected to take 3-3.5 years from property handover.
  • Cautious approach to expanding the franchisee model to maintain quality standards.
  • Focus on orthopedic implant business with potential expansion into other medical devices in the long term.

Shalby Limited continues to navigate challenges while pursuing growth opportunities across its hospital network and implant business. The company's strategy focuses on improving occupancy rates, expanding its domestic patient base, and driving growth in its implant division.

Historical Stock Returns for Shalby

1 Day5 Days1 Month6 Months1 Year5 Years
-1.70%-4.63%-8.50%-3.27%-30.06%+116.75%
More News on Shalby
Explore Other Articles
191.82
-3.32
(-1.70%)